← Back to Search

Multivitamin-mineral supplement

Prenatal Multivitamins for Pregnancy

N/A

Recruiting

Research Sponsored by City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Pregnant women over 18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after 24 weeks of intervention

Awards & highlights

Study Summary

This trial tests if a prenatal multivitamin/multimineral supplement can improve nutrition status in pregnant women and their babies.

Who is the study for?

This trial is for pregnant women over 18 with a single baby, who are not dealing with diabetes, heart conditions, or liver disease before or during pregnancy. It's designed to help those interested in optimizing their nutrition and the health of their unborn child.Check my eligibility

What is being tested?

The study compares two prenatal multivitamins: Ritual Epre Multivitamin-mineral supplement and a control MVI. Participants will be randomly assigned to one of these groups and take the supplements throughout their pregnancy to see which leads to better maternal-fetal nutrition.See study design

What are the potential side effects?

Since both MVIs are commercially available and over-the-counter, side effects should be minimal but may include typical reactions such as nausea or digestive discomfort that some experience from taking vitamins.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am pregnant and over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after 24 weeks of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after 24 weeks of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and after 24 weeks of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Biotin status

Folate status

placental functional gene expression regulation

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Ritual EpreExperimental Treatment1 Intervention

This group will receive 2 Ritual Epre multivitamin-mineral supplement pills daily.

Group II: Control MVIActive Control1 Intervention

For the prenatal arm, this group will receive a control multivitamin-mineral supplement pill and a 200 mg docosahexaenoic acid (DHA) pill that are commercially available.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

City University of New YorkLead Sponsor

17 Previous Clinical Trials

5,583 Total Patients Enrolled

Maimonides Medical CenterOTHER

69 Previous Clinical Trials

15,225 Total Patients Enrolled

Media Library

control MVI (Multivitamin-mineral supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05673070 — N/A

Pregnancy Research Study Groups: Ritual Epre, Control MVI

Pregnancy Clinical Trial 2023: control MVI Highlights & Side Effects. Trial Name: NCT05673070 — N/A

control MVI (Multivitamin-mineral supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05673070 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical trial still ongoing?

"Alas, this clinical trial is not currently enrolling patients. Despite being posted on January 1st 2023 and updated as recently as December 21st 2022, it has reached its patient capacity. Fortunately though, there are 147 other trials actively recruiting participants now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of Ritual Prenatal Multivitamins for Pregnancy

Xinyin Jiang 2023. "Use of Ritual Prenatal Multivitamins for Pregnancy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05673070.